CareDx announced the appointment of two senior executives who will lead initiatives as the company advances its long-term strategic growth plan. CareDx will be sharing its long-term growth strategy during an Investor Day in October. Keith Kennedy brings more than 20 years of experience. As COO, Kennedy will spearhead CareDx’s operational transformation and lead its operational functions. Kennedy most recently served as CFO at PharmaLogic. Jessica Meng brings to CareDx expertise in building commercial strategies for both established companies and entrepreneurial ventures in the pharmaceutical and molecular diagnostics industries. As chief commercial officer, or CCO, Jessica Meng will be responsible for driving CareDx’s commercial growth globally across its portfolio. Meng previously served as CCO at Delfi Diagnostics.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz
- Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls
- Wells Fargo starts tools and diagnostics group with positive bias
- CareDx initiated with an Underweight at Wells Fargo
- Apple, Lineage, OneStream initiated: Wall Street’s top analyst calls